...
首页> 外文期刊>Cytotherapy >Short-term exposure of umbilical cord blood CD34+ cells to granulocyte-macrophage colony-stimulating factor early in culture improves ex vivo expansion of neutrophils
【24h】

Short-term exposure of umbilical cord blood CD34+ cells to granulocyte-macrophage colony-stimulating factor early in culture improves ex vivo expansion of neutrophils

机译:在培养早期将脐带血CD34 +细胞短期暴露于粒细胞-巨噬细胞集落刺激因子可改善中性粒细胞的离体扩增

获取原文
获取原文并翻译 | 示例

摘要

Background aims: Despite the availability of modern antibiotics/ antimycotics and cytokine support, neutropenic infection accounts for the majority of chemotherapy-associated deaths. While transfusion support with donor neutrophils is possible, cost and complicated logistics make such an option unrealistic on a routine basis. A manufactured neutrophil product could enable routine prophylactic administration of neutrophils, preventing the onset of neutropenia and substantially reducing the risk of infection. We examined the use of pre-culture strategies and various cytokine/modulator combinations to improve neutrophil expansion from umbilical cord blood (UCB) hematopoietic stem and progenitor cells (HPC). Methods. Enriched UCB HPC were cultured using either two-phase pre-culture strategies or a single phase using various cytokine/modulator combinations. Outcome was assessed with respect to numerical expansion, cell morphology, granulation and respiratory burst activity. Results. Pre-culture in the absence of strong differentiation signals (e.g. granulocyte colony-stimulating factor; G-CSF) failed to provide any improvement to final neutrophil yields. Similarly, removal of differentiating cells during pre-culture failed to improve neutrophil yields to an appreciable extent. Of the cytokine/modulator combinations, the addition of granulocyte-macrophage (GM)-colony-stimulating factor (CSF) alone gave the greatest increase. In order to avoid production of monocytes, it was necessary to remove GM-CSF on day 5. Using this strategy, neutrophil expansion improved 2.7-fold. Conclusions. Although all cytokines and culture strategies employed have been reported previously to enhance HPC expansion, we found that the addition of GM-CSF alone was sufficient to improve total cell yields maximally. The need to remove GM-CSF on day 5 to avoid monocyte differentiation highlights the context and time-dependent complexity of exogenous signaling in hematopoietic cell differentiation and growth.
机译:背景目标:尽管可获得现代抗生素/抗真菌药和细胞因子支持,但嗜中性白血球减少症仍占大多数与化疗相关的死亡。尽管可以用供体中性粒细胞进行输血支持,但常规的费用和复杂的后勤处理使这种选择不现实。生产的嗜中性粒细胞产品可以使嗜中性粒细胞得以常规预防,从而预防中性粒细胞减少症的发生并大大降低感染的风险。我们研究了使用预培养策略和各种细胞因子/调节剂组合来改善中性粒细胞从脐带血(UCB)造血干细胞和祖细胞(HPC)的扩增。方法。使用两阶段预培养策略或使用各种细胞因子/调节剂组合的单相培养富集的UCB HPC。在数字扩展,细胞形态,肉芽形成和呼吸爆发活性方面评估结果。结果。在没有强烈分化信号(例如粒细胞集落刺激因子; G-CSF)的情况下进行预培养无法改善最终的中性粒细胞产量。类似地,在预培养过程中去除分化细胞不能将嗜中性白细胞的产量提高到可观的程度。在细胞因子/调节剂组合中,单独添加粒细胞-巨噬细胞(GM)-集落刺激因子(CSF)的效果最大。为了避免单核细胞的产生,有必要在第5天去除GM-CSF。使用这种策略,嗜中性粒细胞的扩增提高了2.7倍。结论尽管先前已报道了采用的所有细胞因子和培养策略均可增强HPC的扩增,但我们发现仅添加GM-CSF即可最大程度地提高总细胞产量。在第5天去除GM-CSF以避免单核细胞分化的需要突出了造血细胞分化和生长中外源信号传导的背景和时间依赖性复杂性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号